Currently, prognostic variables in MM are based on the Revised International Staging System (RISS) for MM, and include the albumin level, Beta 2 microglobulin (β2M), LDH level and cytogenetic or fluorescent in situ hybridisation (FISH) profiling [24–26]. This evidence concerns the gene ALB and Miyoshi myopathy.